High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen

Human Pathology

Volumn 30, Issue 6, 1999, Pages 648-654

  Lampert, Irvin A ^a   Wotherspoon, Andrew ^b   Van Noorden, Susan ^b   Hasserjian, Robert P ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

CD23; Cell proliferation; Chronic lymphocytic leukemia; Spleen

Indexed keywords

ALKALINE PHOSPHATASE; CD23 ANTIGEN; IMMUNOGLOBULIN E;

ADULT; AGED; ARTICLE; CANCER GROWTH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLAST; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MALE; PROGNOSIS; PROLYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPLEEN; SPLENECTOMY;

EID: 0033040915     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90089-8     Document Type: Article

References (24)

1. Zwiebel JA, Cheson BD: Chronic lymphocytic leukemia: Staging and prognostic factors. Semin Oncol 25:42-59, 1998
2. Lampert IA, Hegde U, Van Noorden S: The splenic white pulp in chronic lymphocytic leukaemia: A microenvironment associated with CR2 (CD21) expression, cell transformation and proliferation. Leukemia and Lymphoma 1:319-326, 1990
3. Delespesse G, Sarfati M, Hofstetter H: Human IgE-binding factor. Immunol Today 10:159-163, 1989
4. Letellier H, Sarfati M, Delespesse G: Mechanism of formation of IgE-binding factors of different molecular weights. Mol Immunol 26:1105-1112, 1990
5. Kikutnai, Suemura A, Owaki H, et al: Fce receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med 164:1455-1469, 1986
6. Sarfati M, Chevret S, Chastang C, et al: Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 88:4259-4264, 1996
7. Liu Y-J, Xu J, de Bouteiller O, et al: Follicular dendritic cells specifically express the long CR2/CD21 isoform. J Exp Med 185:165-170, 1997
8. Cattoretti G, Becker MHG, Key G, et al: Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:356-363, 1992
9. Ponder BA, Wilkinson MM: Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry. J Histochem Cytochem 29:981-984, 1981
10. Van Krieken J, te Velde J: Normal histology of the human spleen. Am J Surg Pathol 12:777-785, 1988
11. Van Krieken J, von Schilling C, Kluin PM, et al: Splenic marginal zone lymphocytes and related cells in the lymph nodes: A morphologic and immunohistochemical study. HUM PATHOL 20:320-325, 1989
12. Timens W, Poppema S: Lymphocyte compartments in human spleen: An immunohistologic study in normal spleens and non-involved spleens in Hodgkin's disease. Am J Pathol 120:443-454, 1985
13. Van Krieken J, te Velde J: Immunohistology of the human spleen: An inventory of the localization of lymphocyte subpopulations. Histopathology 10:285-294, 1986
14. Stansfeld AG: Low-grade B cell lymphomas, in Stansfeld AG, d'Ardenne AJ: Lymph Node Biopsy Interpretation (ed 2). New York, NY, Churchill Livingstone, 1992, p 231
15. Lukes RJ, Collins RD: New approaches to the classification of the lymphomata. Br J Cancer 31:1-28, 1975 (suppl II)
16. Fournier S, Rubio M, Delespesse G, et al: Role for low-affinity receptor for IgE (CD23) in normal and leukemic B cell proliferation. Blood 84:1881-1886, 1994
17. Sarfati M, Biron D, Lagneaux C, et al: Elevation of IgE binding factors in serum of patients with B cell derived chronic lymphocytic leukemia. Blood 71:94-98, 1988
18. Knauf WU, Ehlers B, Mohr B, et al: Prognostic impact of the serum levels of soluble CD23 in B-cell chronic lymphocytic leukemia. Blood 89:4241-4056, 1997
19. Molica S, Levato D, Dell'Olio M, et al: Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia: Implications for prognosis. Haematologica 81:428-433, 1996
20. Renisch W, Willheim M, Hilgarth M, et al: Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J Clin Oncol 12:2146-2152, 1994
21. Wheeler DJ, Parveen S, Pollock K, et al: Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471. Immunology 95:105-110, 1998
22. Gordon J: B-cell signalling via the C-type lectins CD23 and CD72. Immunol Today 15:411-417, 1994
23. Gagro A, Dasic G, Sabioncello A, et al: Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia. Leukemia and Lymphoma 25:301-311, 1997
24. Timens W, Boes A, Poppema S: Human marginal zone B cells are not an activated B cell subset: Strong expression of CD21 as a putative mediator for rapid B cell activation. Eur J Immunol 19:2263-2166, 1989